This CD133–Smad7 interaction inhibited the SMURF2-induced ubiquitination of Smad7 and increased its half-life, resulting in a reduction in the TGF-β-induced liver fibrosis and apoptosis rates of hepatocytes [372]. The gene discussed is SMAD7; the disease is Hepatic fibrosis.